ACA |
Anti-cardiolipin antibodies |
ALT |
Alanine aminotransferase |
AP |
Alkaline phosphatase |
APS |
Antiphospholipid syndrome |
AT-III |
Antithrombin III |
BCLC |
Barcelona Clinic Liver Cancer |
CT |
Computed tomography |
EV |
Esophageal varices |
FV |
factor V Leiden mutation |
FVL |
Factor V Leiden |
HCC |
Hepatocellular carcinoma |
HE |
Hepatic encephalopathy |
HIV |
Human immunodeficiency virus |
INR |
International normalized ratio |
JAK2 |
Janus Kinase 2 mutation |
LA |
Lupus anticoagulant |
LMWH |
Molecular-weight heparin |
LT |
Liver transplantation |
MELD |
Model for End-Stage Disease |
MRI |
Magnetic resonance imaging |
MTHFR |
Methylenetetrahydrofolate reductase TT677 genotype |
PAI-1 |
Plasminogen activator inhibitor type 1 |
PNH |
Paroxysmal nocturnal hemoglobinuria |
PTHR |
Prothrombin G20210A mutation |
PV |
Polycythemia vera |
PVT |
Portal vein thrombosis |
RCT |
Randomized control trial |
SBP |
Spontaneous bacterial peritonitis |
SMV |
Superior mesenteric vei |
SV |
Splenic vein |
TIPS |
Transjugular intrahepatic portosystemic shunt |
UK |
United Kingdom |
US |
Ultrasound |
VB |
Variceal bleeding |